Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: J Urol. 2012 Sep 19;188(5):1739–1745. doi: 10.1016/j.juro.2012.07.021

Figure 1.

Figure 1

CONSORT flow diagram of study enrollment. Of 372 patients who were assessed for the study, 311 signed informed consent and were randomized to dutasteride versus placebo. Ultimately, 272 patients completed the protocol and received a CEUS with prostate biopsy. No patient was lost to follow-up.